Suppr超能文献

瑞士非常高龄供者肾移植的结局 - 一项全国队列研究。

Outcome of kidney transplantation from very senior donors in Switzerland - a national cohort study.

机构信息

Klinik für Nephrologie und Hypertonie, Inselspital, Bern, Switzerland.

Klinik für Transplantationsimmunologie und Nephrologie, Universitätsspital Basel, Basel, Switzerland.

出版信息

Transpl Int. 2021 Apr;34(4):689-699. doi: 10.1111/tri.13836. Epub 2021 Mar 5.

Abstract

Kidney transplantation from older and marginal donors is effective to confront organ shortage. However, limitations after transplantation of kidneys from very marginal kidney donors remain unclear. We compared patient and graft outcome, achieved allograft function and quality of life of renal transplantations from Very Senior Donors (VSD, defined as donors aged 70 years and older) with Senior Donors (SD, aged 60-70 years) and Regular Donors (RD, aged younger than 60 years) in Switzerland. We evaluated the outcome of 1554 adult recipients of deceased donor kidney transplantations from 05/2008 to 12/2019; median follow-up was 4.7 years. Failure-free survival (freedom from graft loss or death), glomerular filtration rate (eGFR), and quality of life at 12 months were analyzed for RD (reference group, n = 940), SD (n = 404), and VSD (n = 210). Failure-free survival decreased with increasing donor age, mainly attributable to premature graft loss. Still, overall 5-year failure-free survival reached 83.1%, 81.0%, and 64.0% in the RD, SD, and VSD subgroups, respectively. eGFR 12 months post-transplantation was significantly higher in RD compared with SD and VSD. The acceptance rate of donor candidates for kidney TPL was 78% for the entire cohort (87% for RD, 79% for SD, and 56% for VSD). Deceased donor kidney transplantation from donors aged 70 years or older is associated with an inferior, yet acceptable failure-free outcome, with sustained quality of life.

摘要

从老年和边缘供体进行肾移植是应对器官短缺的有效方法。然而,从非常边缘供体肾移植后的限制仍不清楚。我们比较了瑞士非常高龄供体(VSD,定义为年龄 70 岁及以上的供体)、高龄供体(SD,年龄 60-70 岁)和常规供体(RD,年龄小于 60 岁)的肾移植患者和移植物的结局、获得的同种异体移植功能和生活质量。我们评估了 2008 年 5 月至 2019 年 12 月期间 1554 例接受死亡供体肾移植的成年患者的结局;中位随访时间为 4.7 年。无失败存活率(免于移植物丢失或死亡)、肾小球滤过率(eGFR)和 12 个月时的生活质量用于分析 RD(参考组,n=940)、SD(n=404)和 VSD(n=210)。无失败存活率随供体年龄的增加而降低,主要归因于移植物的过早丢失。尽管如此,总体 5 年无失败存活率分别在 RD、SD 和 VSD 亚组中达到 83.1%、81.0%和 64.0%。移植后 12 个月时 eGFR 在 RD 组明显高于 SD 组和 VSD 组。整个队列中,肾 TPL 供体候选人的接受率为 78%(RD 组为 87%,SD 组为 79%,VSD 组为 56%)。从年龄 70 岁或以上的供体进行死亡供体肾移植与较差但可接受的无失败结局相关,并保持生活质量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验